{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:51:11Z","timestamp":1793321471581,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100018133","name":"VitreoRetinal Surgery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00417-023-06112-2","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T07:02:37Z","timestamp":1684998157000},"page":"2813-2819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intravitreal triple therapy with vancomycin, ceftazidime, and moxifloxacin for bacterial endophthalmitis: A Twelve-year experience"],"prefix":"10.1007","volume":"261","author":[{"given":"Kenneth J.","family":"Taubenslag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"Cherney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriji N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice C.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony B.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"6112_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0002-9394(14)71959-2","volume":"122","author":"DP Han","year":"1996","unstructured":"Han DP, Wisniewski SR, Wilson LA et al (1996) Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 122:1\u201317","journal-title":"Am J Ophthalmol"},{"key":"6112_CR2","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.ophtha.2014.02.001","volume":"121","author":"RC Gentile","year":"2014","unstructured":"Gentile RC, Shukla S, Shah M et al (2014) Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review. Ophthalmology 121:1634\u20131642","journal-title":"Ophthalmology"},{"key":"6112_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10792-014-0015-9","volume":"35","author":"AK Reddy","year":"2015","unstructured":"Reddy AK, Reddy RR, Paruvelli MR et al (2015) Susceptibility of bacterial isolates to vancomycin and ceftazidime from patients with endophthalmitis: Is there a need to change the empirical therapy in suspected bacterial endophthalmitis? Int Ophthalmol 35:37\u201342","journal-title":"Int Ophthalmol"},{"key":"6112_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1869-5760-3-62","volume":"3","author":"A Jindal","year":"2013","unstructured":"Jindal A, Pathengay A, Khera M et al (2013) Combined ceftazidime and amikacin resistance among Gram-negative isolates in acute-onset postoperative endophthalmitis: prevalence, antimicrobial susceptibilities, and visual acuity outcome. J Ophthalmic Inflamm Infect 3:62","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"6112_CR5","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/IAE.0b013e31820f4b9d","volume":"31","author":"A Pathengay","year":"2011","unstructured":"Pathengay A, Moreker MR, Puthussery R et al (2011) Clinical and microbiologic review of culture-proven endophthalmitis caused by multidrug-resistant bacteria in patients seen at a tertiary eye care center in southern India. Retina 31:1806\u20131811","journal-title":"Retina"},{"key":"6112_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00417-019-04261-x","volume":"257","author":"EY Choi","year":"2019","unstructured":"Choi EY, Han JY, Lee H et al (2019) Impact of antibiotic resistance of pathogens and early vitrectomy on the prognosis of infectious endophthalmitis: a 10-year retrospective study. Graefes Arch Clin Exp Ophthalmol 257:805\u2013813","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6112_CR7","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/bjophthalmol-2015-307722","volume":"100","author":"N Relhan","year":"2016","unstructured":"Relhan N, Albini TA, Pathengay A et al (2016) Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment. Br J Ophthalmol 100:446\u2013452","journal-title":"Br J Ophthalmol"},{"key":"6112_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ajoc.2018.02.030","volume":"10","author":"HS Shivaramaiah","year":"2018","unstructured":"Shivaramaiah HS, Relhan N, Pathengay A et al (2018) Endophthalmitis caused by gram-positive bacteria resistant to vancomycin: Clinical settings, causative organisms, antimicrobial susceptibilities, and treatment outcomes. Am J Ophthalmol Case Rep 10:211\u2013214","journal-title":"Am J Ophthalmol Case Rep"},{"key":"6112_CR9","doi-asserted-by":"publisher","first-page":"9745","DOI":"10.1038\/s41598-019-46236-2","volume":"9","author":"H Miyake","year":"2019","unstructured":"Miyake H, Miyazaki D, Shimizu Y et al (2019) Toxicities of and inflammatory responses to moxifloxacin, cefuroxime, and vancomycin on retinal vascular cells. Sci Rep 9:9745","journal-title":"Sci Rep"},{"key":"6112_CR10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jcrs.2007.10.046","volume":"34","author":"M Kernt","year":"2008","unstructured":"Kernt M, Neubauer AS, Ulbig MW et al (2008) In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment. J Cataract Refract Surg 34:480\u2013488","journal-title":"J Cataract Refract Surg"},{"key":"6112_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/00006982-200602000-00011","volume":"26","author":"E Aydin","year":"2006","unstructured":"Aydin E, Kazi AA, Peyman GA, Esfahani MR (2006) Intravitreal toxicity of moxifloxacin. Retina 26:187\u2013190","journal-title":"Retina"},{"key":"6112_CR12","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1167\/iovs.05-0702","volume":"47","author":"H Gao","year":"2006","unstructured":"Gao H, Pennesi ME, Qiao X et al (2006) Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models. Invest Ophthalmol Vis Sci 47:1606\u20131611","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6112_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/jop.2011.0021","volume":"27","author":"YB Sakalar","year":"2011","unstructured":"Sakalar YB, Ozekinci S, Celen MK (2011) Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone. J Ocul Pharmacol Ther 27:593\u2013598","journal-title":"J Ocul Pharmacol Ther"},{"key":"6112_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/02713680701215595","volume":"32","author":"SS Ermis","year":"2007","unstructured":"Ermis SS, Cetinkaya Z, Kiyici H et al (2007) Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis. Curr Eye Res 32:337\u2013344","journal-title":"Curr Eye Res"},{"key":"6112_CR15","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.2147\/OPTH.S44212","volume":"7","author":"DJ Jacobs","year":"2013","unstructured":"Jacobs DJ, Grube TJ, Flynn HW et al (2013) Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body. Clin Ophthalmol 7:1727\u20131730","journal-title":"Clin Ophthalmol"},{"key":"6112_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4103\/ijo.IJO_587_20","volume":"69","author":"A Agarwal","year":"2021","unstructured":"Agarwal A, Nagpal M (2021) Intravitreal moxifloxacin injections in acute post-cataract surgery endophthalmitis: Efficacy and safety. Indian J Ophthalmol 69:326\u2013330","journal-title":"Indian J Ophthalmol"},{"key":"6112_CR17","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1097\/IAE.0b013e31820039af","volume":"31","author":"S Mehta","year":"2011","unstructured":"Mehta S, Armstrong BK, Kim SJ et al (2011) Long-term potency, sterility, and stability of vancomycin, ceftazidime, and moxifloxacin for treatment of bacterial endophthalmitis. Retina Phila Pa 31:1316\u20131322","journal-title":"Retina Phila Pa"},{"key":"6112_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00417-017-3608-y","volume":"255","author":"A Grzybowski","year":"2017","unstructured":"Grzybowski A, Brona P, Kim SJ (2017) Microbial flora and resistance in ophthalmology: a review. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 255:851\u2013862","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"6112_CR19","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.ophtha.2011.03.017","volume":"118","author":"SB Dave","year":"2011","unstructured":"Dave SB, Toma HS, Kim SJ (2011) Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study. Ophthalmology 118:2035\u20132040","journal-title":"Ophthalmology"},{"key":"6112_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0039-6257(97)00005-2","volume":"41","author":"DB Roth","year":"1997","unstructured":"Roth DB, Flynn HW (1997) Antibiotic selection in the treatment of endophthalmitis: the significance of drug combinations and synergy. Surv Ophthalmol 41:395\u2013401","journal-title":"Surv Ophthalmol"},{"key":"6112_CR21","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/jac\/dkg238","volume":"51","author":"MA Dawis","year":"2003","unstructured":"Dawis MA, Isenberg HD, France KA, Jenkins SG (2003) In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms. J Antimicrob Chemother 51:1203\u20131211","journal-title":"J Antimicrob Chemother"},{"key":"6112_CR22","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1128\/AAC.40.12.2802","volume":"40","author":"KP Klugman","year":"1996","unstructured":"Klugman KP, Capper T, Bryskier A (1996) In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampin. Antimicrob Agents Chemother 40:2802\u20132804","journal-title":"Antimicrob Agents Chemother"},{"key":"6112_CR23","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/jac\/47.5.701","volume":"47","author":"M Perrig","year":"2001","unstructured":"Perrig M, Acosta F, Cottagnoud M et al (2001) Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro. J Antimicrob Chemother 47:701\u2013704","journal-title":"J Antimicrob Chemother"},{"key":"6112_CR24","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1128\/AAC.37.11.2506","volume":"37","author":"CA Day","year":"1993","unstructured":"Day CA, Marceau-Day ML, Day DF (1993) Increased susceptibility of Pseudomonas aeruginosa to ciprofloxacin in the presence of vancomycin. Antimicrob Agents Chemother 37:2506\u20132508","journal-title":"Antimicrob Agents Chemother"},{"key":"6112_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1167\/iovs.05-1124","volume":"47","author":"MN Iyer","year":"2006","unstructured":"Iyer MN, He F, Wensel TG et al (2006) Clearance of intravitreal moxifloxacin. Invest Ophthalmol Vis Sci 47:317\u2013319","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6112_CR26","doi-asserted-by":"crossref","unstructured":"(1995) Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 113(12):1479\u20131496","DOI":"10.1001\/archopht.1995.01100120009001"},{"key":"6112_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ophtha.2019.08.026","volume":"127","author":"S Pershing","year":"2020","unstructured":"Pershing S, Lum F, Hsu S et al (2020) Endophthalmitis after Cataract Surgery in the United States: A Report from the Intelligent Research in Sight Registry, 2013\u20132017. Ophthalmology 127:151\u2013158","journal-title":"Ophthalmology"},{"key":"6112_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.survophthal.2019.12.005","volume":"65","author":"SN Patel","year":"2020","unstructured":"Patel SN, Gangaputra S, Sternberg P, Kim SJ (2020) Prophylaxis measures for postinjection endophthalmitis. Surv Ophthalmol 65:408\u2013420","journal-title":"Surv Ophthalmol"},{"key":"6112_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00417-011-1851-1","volume":"250","author":"C Irigoyen","year":"2012","unstructured":"Irigoyen C, Ziahosseini K, Morphis G et al (2012) Endophthalmitis following intravitreal injections. Graefes Arch Clin Exp Ophthalmol 250:499\u2013505","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-023-06112-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-023-06112-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-023-06112-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T06:05:36Z","timestamp":1696053936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-023-06112-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6112"],"URL":"https:\/\/doi.org\/10.1007\/s00417-023-06112-2","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"assertion":[{"value":"22 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review board as well as the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The Institutional Review Board of Vanderbilt University Medical Center approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Due to the characteristics of the study, the Institutional Review Board of Vanderbilt University Medical Center waived the need for written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}